(Q37780547)

English

Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool

scientific article published on September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1 reference

Europe PubMed Central

Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1 reference

based on heuristic

inferred from title

author name string

Yasufumi Kaneda

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

language of work or name

0 references

publication date

1 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Expert Opinion on Drug Delivery

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1079-1093

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Nuclear imaging of cancer cell therapies

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Lipid Bilayers and Biomembranes

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Viral-based gene delivery and regulated gene expression for targeted cancer therapy

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Occurrence of leukaemia following gene therapy of X-linked SCID.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Gene therapy death prompts review of adenovirus vector

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Non-viral vectors for cancer therapy

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Progress in developing cationic vectors for non-viral systemic gene therapy against cancer

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Nonviral gene delivery: principle, limitations, and recent progress

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Human gene therapy for malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human interferon beta gene using cationic liposomes

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Endosomes, lysosomes: their implication in gene transfer

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

The role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Tumour-targeted nanomedicines: principles and practice.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Nanoparticle therapeutics: an emerging treatment modality for cancer

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Nanocarriers as an emerging platform for cancer therapy

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma: results of a phase II study

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma: report of the pivotal phase 2 study.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Targeted drug delivery via the folate receptor

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Limits of CD133 as a marker of glioma self-renewing cells

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Enhanced percolation and gene expression in tumor hypoxia by PEGylated polyplex micelles.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Potential of atelocollagen-mediated systemic antisense therapeutics for inflammatory disease

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

The mechanism of naked DNA uptake and expression

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Direct gene transfer into nonhuman primate myofibers in vivo

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Gene therapy progress and prospects: electroporation and other physical methods.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

MicroRNAs targeting mutant K-ras by electrotransfer inhibit human colorectal adenocarcinoma cell growth in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Sonoporation mediated immunogene therapy of solid tumors

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Local delivery system of cytotoxic agents to tumors by focused sonoporation.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Effect of sonoporation on cationic liposome-mediated IFNbeta gene therapy for metastatic hepatic tumors of murine colon cancer

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Hydrodynamic delivery of DNA.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies. Part II: clinical protocol

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Hydrodynamic gene delivery to the liver: theoretical and practical issues for clinical application

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Hydrodynamics-based gene delivery of naked DNA encoding fetal liver kinase-1 gene effectively suppresses the growth of pre-existing tumors

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Hydrodynamic limb vein delivery of a xenogeneic DNA cancer vaccine effectively induces antitumor immunity

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Genetic immunization by jet injection of targeted pDNA-coated nanoparticles

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Pseudovirions as vehicles for the delivery of siRNA

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Gene therapy using HVJ-liposomes: the best of both worlds?

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Sendai virus-induced cell fusion

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

RNA melanoma vaccine: induction of antitumor immunity by human glycoprotein 100 mRNA immunization.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Eradication of hepatocellular carcinoma xenografts by radiolabelled, lipiodol-inducible gene therapy

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Nanoparticles for the delivery of genes and drugs to human hepatocytes

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Gene therapy of liver tumors with human liver-specific nanoparticles.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Multicenter phase I study of repeated intratumoral delivery of adenoviral p53 in patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Next generation of immunotherapy for melanoma

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Stem cell collection and gene transfer in Fanconi anemia

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Gene therapy progress and prospects cancer: oncolytic viruses.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic Acid

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Toxicity of cationic lipid-DNA complexes

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Gene therapy: trials and tribulations

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

A new therapy for highly effective tumor eradication using HVJ-E combined with chemotherapy

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.510511

21 January 2018

Identifiers

10.1517/17425247.2010.510511

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37780547&oldid=1728081441"